Cantor Fitzgerald Issues Negative Estimate for AXSM Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for shares of Axsome Therapeutics in a report released on Wednesday, February 19th. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will earn ($4.15) per share for the year, down from their […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for shares of Axsome Therapeutics in a report released on Wednesday, February 19th. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will earn ($4.15) per share for the year, down from their […]
